| 摘要 |
The present invention concerns a pharmaceutical combination comprising (a) dolutegravir, (b) emtricitabine and (c) tenofovir or a prodrug thereof, wherein preferably the compounds are present in a specific weight ratio and/or in specific amounts, for use as a medicament, preferably in treatment of viral infection/disease such as an HIV infection. Further, the present invention relates to a pharmaceutical composition comprising the pharmaceutical combination and optionally further pharmaceutical excipient(s). |
